Quoin Pharmaceuticals LT-ADRQNRX
13F holders, Q1 2025 (March 31)1holders
$0.22avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Quoin Pharmaceuticals LT-ADR (QNRX) in their 13F filings. The largest holder was SBI Securities Co., Ltd. ($24).
- Company
- Quoin Pharmaceuticals LT-ADR
- CUSIP
- 74907L409
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $24 |
| Exits | 0 | $0 |
Ownership 1 holders
| SBI Securities Co., Ltd. | 0.00% | New | 108 | $24 |
"% of holder's portfolio" is QNRX's weight in each manager's 13F, not the share of Quoin Pharmaceuticals LT-ADR the manager owns.